Inside Job: Methods for Delivering Proteins to the Interior of Mammalian Cells https://t.co/JPemw1Qr60
— Thomas Pulinilkunnil (@tpulinil) August 27, 2017
Original Article: Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease (CANTOS) https://t.co/HVGAvr62SK #ESCCongress pic.twitter.com/tzHmbtX9cY
— NEJM (@NEJM) August 27, 2017
Nice visuals on the effectiveness of vaccineshttps://t.co/7m5nvJjVST
— David States (@statesdj) August 19, 2017
The prognostic value of infiltrating immune cells in cancer - #openaccess review by Barnes & Amir https://t.co/LWCLGod7i1 pic.twitter.com/vYLlUxjWtK
— BJC (@BrJCancer) August 14, 2017
Here comes that big paper on #CRISPR gene editing in human embryos https://t.co/cVGGUdFmAA pic.twitter.com/AEdCstzhWK
— Andy Biotech (@AndyBiotech) August 2, 2017
And a critique of it too - from the Knoepfler lab: https://t.co/HrUuQHxUZn
— Sally Church (@MaverickNY) August 2, 2017
Back to the drawing board!
— Anirban Maitra (@Aiims1742) July 14, 2017
Only 10-15% concordance betn @FoundationATCG & @GuardantHealth panels in #BreastCancer https://t.co/BcWzSyjdDV
14 patients in anti-PD-1/anti-PD-L1 therapy for #lungcancer have shown hair repigmentation during Tx https://t.co/V54ut3yyGE #LCSM pic.twitter.com/65XLquOAAt
— JAMA Dermatology (@JAMADerm) July 12, 2017
The Economics of Indication-Based Drug Pricinghttps://t.co/oBio60jezz pic.twitter.com/r0COO4uCmh
— Andy Biotech (@AndyBiotech) July 13, 2017
BOOM! New method for ChIP without antibodies: CRISPR/Cas9-APEX-mediated proximity labeling in living cells! #ASAPbio https://t.co/kBo01IVUR6
— Leslie Vosshall (@pollyp1) July 5, 2017